Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Riley Griffin
Stay informed with Riley Griffin’s coverage and analysis for Fortune.
Tech
Meta gains after Zuckerberg predicts ‘really big year’ in AI
By
Riley Griffin
and
Bloomberg
Politics
Bernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives
By
Madison Muller
,
Naomi Kresge
, and others
Health
Federal health agency gives cannabis industry a big lift by endorsing looser drug rules for marijuana
By
Jonathan Roeder
,
Riley Griffin
, and others
Health
Biden administration pushes Walgreens, CVS and Walmart to tout drug cost benefits of Inflation Reduction Act as drugmakers sue government
By
Riley Griffin
and
Bloomberg
Health
Declassified report shows Covid-19 origins remain a mystery, despite Wuhan lab researchers falling sick in 2019
By
Riley Griffin
and
Bloomberg
Finance
You have until May 31 to order free COVID tests before the federal government ends the program after mailing 750 million kits
By
Riley Griffin
and
Bloomberg
Biden to spur biomanufacturing, reduce reliance on China with executive order
By
Riley Griffin
and
Bloomberg
Health
Americans will have to pay for COVID vaccines and treatments as soon as January because Congress has run out of money to buy them
By
Riley Griffin
,
Alexander Ruoff
, and others
Health
Johnson & Johnson to stop selling talc-based baby powder as cancer lawsuits pile on
By
Riley Griffin
,
Jef Feeley
, and others
Health
Fauci to retire before end of Biden’s current term after five decades of working in government
By
Riley Griffin
,
Jeannie Baumann
, and others
Health
Pfizer says three COVID shots is ‘highly effective’ in children under 5
By
Riley Griffin
and
Bloomberg
International
Pfizer pauses clinical trials in Russia, says it will continue to send drugs to patients
By
Riley Griffin
and
Bloomberg
Finance
The COVID bump looks over for Pfizer as 2022 forecast falls short of Wall Street estimates, stock drops
By
Riley Griffin
and
Bloomberg
Health
Pfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
By
Riley Griffin
and
Bloomberg
Health
Johnson & Johnson turn to influencers for help in reaching Gen-Z shoppers
By
Riley Griffin
,
Kim Bhasin
, and others